Vol 2, No 1 (1998)
Prace oryginalne
Published online: 2000-03-08
Get Citation

Polymorphism of the angiotensin-converting enzyme gene in patients with coronary heart disease below 50 years of age with and without arterial hypertension

Marcin Gruchała, Dariusz Ciećwierz, Radosław Targoński, Witold Dubaniewicz, Karolina Ochman, Joanna Wiśniewska-Szmyt, Andrzej Rykaczewski, Piotr Jagodziński, Piotr Romanowski, Janusz Limon, Andrzej Rynkiewicz
Nadciśnienie tętnicze 1998;2(1):27-33.
Vol 2, No 1 (1998)
Prace oryginalne
Published online: 2000-03-08

Abstract


Background The DD genotype of the angiotensin-converting enzyme (ACE) gene has been proposed as an independent risk factor for cardiovascular diseases. To the present day studies performed in different populations have displayed contradictory results. The aim of our case-control study was to assess the risk of CHD, myocardial infarction and arterial hypertension associated with the insertion/deletion ACE gene polymorphism (I/D ACE) among subjects below 50 years of age.
Methods We compared 99 consecutive patients with CHD confirmed by elective coronarography (mean age 44 ± 4 years, 95 males and 4 females, 76% survived MI, 35% were hypertensive) with 109 controls (negative history of CHD and normal ecg) matched for age and sex (mean age 44 ± 5 years, 100 males, 9 females; 42% were hypertensive). In addition the measurement of standard risk factors was carried out. The polymerase chain reaction and agarose gel electrophoresis were used to determine the ACE I/D genotype.
Results There was no significant difference in the genotype distribution between subjects with CHD (DD 36%, ID 42%, II 22%) and controls (DD 30%, ID 54%, II 16%) p = 0.35. Both study populations were in Hardy-Weinberg equilibrium. In CHD subjects with positive MI history the genotype distribution (DD 42%, ID 38%, II 20%) was not significantly different from controls either p = 0.11. DD genotype frequency was not signifficantly smaller in hypertensive CHD patients in comparison to hypertensive controls (24% vs 30%, p = 0.54). There was no significant difference in DD genotype frequency between normotensive CHD patients and normotensive controls (45% vs 30%, p = 0.08). The deletion genotype was significantly less frequent among hypertensive CHD subjects in comparison to normotensive CHD subjects (24% vs 45%, p < 0.05). In multiple vesel CHD disease (n = 66) DD genotype was observed with similar frequency as in controls (36% vs 30%, p = 0.3). Distribution of the common atherosclerosis risk factors such as: age, BMI, plasma cholesterol and triglicerydes, diabetes, smoking habits was independent from I/D ACE polymorphism in both studied groups.
Conclusion The DD genotype of ACE gene seems not to be associated with coronary heart disease or arterial hypertension among subjects below 50 years of age.

Abstract


Background The DD genotype of the angiotensin-converting enzyme (ACE) gene has been proposed as an independent risk factor for cardiovascular diseases. To the present day studies performed in different populations have displayed contradictory results. The aim of our case-control study was to assess the risk of CHD, myocardial infarction and arterial hypertension associated with the insertion/deletion ACE gene polymorphism (I/D ACE) among subjects below 50 years of age.
Methods We compared 99 consecutive patients with CHD confirmed by elective coronarography (mean age 44 ± 4 years, 95 males and 4 females, 76% survived MI, 35% were hypertensive) with 109 controls (negative history of CHD and normal ecg) matched for age and sex (mean age 44 ± 5 years, 100 males, 9 females; 42% were hypertensive). In addition the measurement of standard risk factors was carried out. The polymerase chain reaction and agarose gel electrophoresis were used to determine the ACE I/D genotype.
Results There was no significant difference in the genotype distribution between subjects with CHD (DD 36%, ID 42%, II 22%) and controls (DD 30%, ID 54%, II 16%) p = 0.35. Both study populations were in Hardy-Weinberg equilibrium. In CHD subjects with positive MI history the genotype distribution (DD 42%, ID 38%, II 20%) was not significantly different from controls either p = 0.11. DD genotype frequency was not signifficantly smaller in hypertensive CHD patients in comparison to hypertensive controls (24% vs 30%, p = 0.54). There was no significant difference in DD genotype frequency between normotensive CHD patients and normotensive controls (45% vs 30%, p = 0.08). The deletion genotype was significantly less frequent among hypertensive CHD subjects in comparison to normotensive CHD subjects (24% vs 45%, p < 0.05). In multiple vesel CHD disease (n = 66) DD genotype was observed with similar frequency as in controls (36% vs 30%, p = 0.3). Distribution of the common atherosclerosis risk factors such as: age, BMI, plasma cholesterol and triglicerydes, diabetes, smoking habits was independent from I/D ACE polymorphism in both studied groups.
Conclusion The DD genotype of ACE gene seems not to be associated with coronary heart disease or arterial hypertension among subjects below 50 years of age.
Get Citation

Keywords

ACE polymorphism; coronary heart disease; myocardial infarction; arterial hypertension

About this article
Title

Polymorphism of the angiotensin-converting enzyme gene in patients with coronary heart disease below 50 years of age with and without arterial hypertension

Journal

Arterial Hypertension

Issue

Vol 2, No 1 (1998)

Pages

27-33

Published online

2000-03-08

Bibliographic record

Nadciśnienie tętnicze 1998;2(1):27-33.

Keywords

ACE polymorphism
coronary heart disease
myocardial infarction
arterial hypertension

Authors

Marcin Gruchała
Dariusz Ciećwierz
Radosław Targoński
Witold Dubaniewicz
Karolina Ochman
Joanna Wiśniewska-Szmyt
Andrzej Rykaczewski
Piotr Jagodziński
Piotr Romanowski
Janusz Limon
Andrzej Rynkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl